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ecent ﬁndings have shown that embryonic vascular
progenitor cells are capable of differentiating into
mural and endothelial cells. However, the molecular
mechanisms that regulate their differentiation, proliferation,
and endothelial sheet formation remain to be elucidated.
Here, we show that members of the transforming growth
 
factor (TGF)-
 
 
 
 superfamily play important roles during
differentiation of vascular progenitor cells derived from
mouse embryonic stem cells (ESCs) and from 8.5–days
postcoitum embryos. TGF-
 
 
 
 and activin inhibited prolifera-
R
 
tion and sheet formation of endothelial cells. Interestingly,
SB-431542, a synthetic molecule that inhibits the kinases
of receptors for TGF-
 
 
 
 and activin, facilitated proliferation
and sheet formation of ESC-derived endothelial cells.
Moreover, SB-431542 up-regulated the expression of
claudin-5, an endothelial speciﬁc component of tight
junctions. These results suggest that endogenous TGF-
 
 
 
/
activin signals play important roles in regulating vascular
growth and permeability.
 
Introduction
 
Embryonic vessels are thought to be formed by endothelial
cells that arise from Flk1-expressing (Flk1
 
 
 
) mesoderm
cells, surrounded by mural cells derived from mesoderm,
neural crest, or epicardial cells. This embryonic paradigm,
referred to as vasculogenesis, contrasts with angiogenesis, the
term applied to the post-natal neovascularization that results
from the proliferation and remodelling of differentiated
endothelial cells from preexisting capillaries (Risau, 1997).
Recently, embryonic stem cell (ESC)–derived vascular
progenitor cells have been shown to differentiate into both
mural and endothelial cells (Yamashita et al., 2000; Marchetti
et al., 2002; Ema et al., 2003). Moreover, bone marrow–
derived vascular progenitor cells circulating in adult peripheral
blood have been shown to include progenitor cells giving
rise to both types of cells (Asahara et al., 1997; Sata et al.,
2002), and to contribute to angiogenesis.
Endothelial cell tyrosine kinase receptors for VEGFs have
been implicated in the regulation of differentiation, growth,
and integrity of endothelial cells. VEGF stimulates endothelial
differentiation of vascular progenitor cells derived from ESC
(Yamashita et al., 2000) and adult bone marrow (Asahara et
al., 1997). VEGF also regulates growth of differentiated
endothelial cells, and increases vascular permeability (Senger
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et al., 1983). Although these properties of VEGF are of great
importance in the processes of vasculogenesis and angiogen-
esis, VEGF may contribute to tissue edema because angio-
genesis is accompanied by an increase in vascular permeabil-
ity followed by vessel sprouting.
VEGF acts exclusively on endothelial cells; however, inter-
action between endothelial cells and mural cells (pericytes
and vascular smooth muscle cells) is essential for develop-
ment of vascular tissues and maintenance of their homeosta-
sis in both embryonic and adult tissues (Folkman and
D’Amore, 1996). TGF-
 
 
 
 superfamily proteins have been
implicated as one of cytokines that serve such interaction
(Carmeliet, 2000).
Members of the TGF-
 
 
 
 superfamily signal via hetero-
meric complexes of type II and type I serine/threonine ki-
nase receptors. Upon ligand binding, the constitutively
active type II receptor kinase phosphorylates the type I re-
ceptor which, in turn, activates the downstream signal trans-
duction cascades, including Smad pathways. Activins and
TGF-
 
 
 
s bind to type I receptors known as activin receptor-
like kinase (ALK)-4 and -5, respectively. The activated type I
receptors phosphorylate receptor-regulated Smad (R-Smad)
proteins. Smad2 and 3 transduce signals for TGF-
 
 
 
s and ac-
tivins, whereas Smad1, 5, and 8 are specific for signaling of
bone morphogenetic proteins (BMPs; Massague, 1998). As
an exception, ALK-1, specifically expressed in endothelial
cells, binds TGF-
 
 
 
 and activates Smad1/5 pathways (Oh et
al., 2000).
The roles of the TGF-
 
 
 
 superfamily in vasculogenesis
have been suggested by the findings that knockout mice de-
ficient in various TGF-
 
 
 
 superfamily signaling components
exhibit defects in vascular tissues (Goumans and Mummery,
2000). Moreover, heterozygous mutations in human genes
coding for endoglin, an accessory protein for the TGF-
 
 
 
 re-
ceptor complex, and/or ALK-1 cause hereditary hemor-
rhagic telangiectasia (Marchuk, 1998). However, the lack of
in vitro systems consisting of pure populations of these cel-
lular lineages has hampered dissection of the roles of TGF-
 
 
 
superfamily signaling in vascular development.
To elucidate the roles of TGF-
 
 
 
 superfamily signaling in
vascular differentiation from their progenitors, we used in
vitro differentiation systems derived from mouse ESC and
8.5–days postcoitum (dpc) embryos. We show that TGF-
 
 
 
and activin inhibit proliferation and sheet formation of
ESC-derived endothelial cells. The effects of TGF-
 
 
 
 on en-
dothelial integrity are at least partly mediated by its down-
regulation of the expression of claudin-5, an endothelial
specific component of tight junctions (TJs). Interestingly,
SB-431542, a synthetic molecule that inhibits the kinases of
receptors for TGF-
 
 
 
 and activin, facilitated proliferation
and sheet formation of ESC-derived endothelial cells. Finally,
we show that TGF-
 
 
 
 down-regulated the growth and integ-
rity of endothelial cells derived from 8.5-dpc embryos,
whereas SB-431542 exhibited the opposite effects. These re-
sults suggest that endogenous TGF-
 
 
 
/activin signals play im-
portant roles in regulating vascular growth and permeability.
 
Results
 
TGF-
 
 
 
 and activin inhibit formation of ESC-derived 
endothelial sheets
 
According to a previous report (Yamashita et al., 2000), un-
differentiated mouse ESCs were cultured for 3 d on collagen
IV–coated dishes with 10% FCS to induce Flk1
 
 
 
 cells,
which were purified by cell sorting using anti-Flk1 antibody.
After an additional 3 d of culture of Flk1
 
 
 
 cells with 10%
FCS, we obtained cells positive for a mural cell marker,
 
 
 
-smooth muscle actin (SMA; Fig. 1 a). When 30 ng/ml
VEGF was added, we were able to obtain platelet-endothe-
lial cell adhesion molecule 1 (PECAM1)–positive sheets of
endothelial cells. The remaining cells surrounding the sheets
were positive for SMA.
To examine the effects of TGF-
 
 
 
 superfamily signals on
ESC-derived in vitro vasculogenesis, we studied the expres-
Figure 1. Effects of TGF-  superfamily 
members on differentiation of ESC-
derived Flk1  cells into endothelial and 
mural cells. (a) PECAM1 (purple) and 
SMA (brown) immunostaining of CCE 
cell–derived vascular cells. ESC-derived 
Flk1  cells were treated or not with VEGF 
in the presence of 10% FCS. The cells 
were also treated with BMP7, TGF- , 
activin, TGF-    10  g/ml anti–TGF-  
antibodies, and activin   200 ng/ml 
follistatin in the presence of VEGF and 
10% FCS. (b) CCE cell–derived Flk1  
cells were treated with different doses of 
TGF-  in the presence of VEGF and 10% 
FCS. Bars: (a and b) 100  m. 
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sion of various TGF-
 
 
 
 superfamily signaling components by
semi-quantitative RT-PCR analysis (Fig. 2). ESC-derived
Flk1
 
 
 
 cells (Flk1
 
 
 
), mural cells (MC), and mixed popula-
tions of endothelial and mural cells (EC 
 
  
 
MC) expressed
transcripts for most components of TGF-
 
 
 
 superfamily sig-
naling pathways, suggesting that they are capable of respond-
ing to BMPs, TGF-
 
 
 
s, and activins. Next, we examined the
effects of the TGF-
 
 
 
 superfamily proteins on the in vitro vas-
cular differentiation of ESC-derived Flk1
 
 
 
 cells. Although
BMP7 did not exhibit significant effects, TGF-
 
 
 
 and activin
led to the decrease in PECAM1
 
 
 
 sheets of endothelial cells
(Fig. 1 a). Moreover, the effects of TGF-
 
 
 
 and activin on
PECAM1
 
 
 
 sheets of endothelial cells were reversed by the
addition of anti–TGF-
 
 
 
 neutralizing antibody and follista-
tin, a natural extracellular inhibitor of activin, respectively.
Goumans et al. (2002) showed that the response of mouse
embryonic endothelial cells to TGF-
 
 
 
 is biphasic, with
ALK-1–mediated positive effects on growth and migration
at low doses (0.25–0.5 ng/ml) and ALK-5–mediated nega-
tive effects at high doses (2.5 ng/ml and higher). To examine
whether TGF-
 
 
 
 exhibits biphasic effects in ESC-derived
vascular cells, different doses of TGF-
 
 
 
 were added to the
culture of Flk1
 
 
 
 cells in the presence of VEGF (Fig. 1 b).
The formation of endothelial sheet was significantly inhib-
ited at 0.03 ng/ml, and its inhibition reached a maximum at
1 ng/ml, which remained at this level at higher doses (Fig. 1
b). These results suggest that TGF-
 
 
 
 does not exhibit bipha-
sic effects in the ESC-derived endothelial sheet formation.
 
TGF-
 
 
 
 receptor kinase inhibitors enhance growth 
and integrity of ESC-derived endothelial cells
 
Next, we attempted to enhance formation of endothelium
by inhibiting endogenous TGF-
 
 
 
 and activin signaling.
First, we added anti–TGF-
 
 
 
 neutralizing antibody, follista-
tin or both of them to culture containing VEGF in the
absence of exogenous TGF-
 
 
 
 or activin. Neither of the ex-
tracellular inhibitors exhibited significant effects on the for-
mation of endothelial sheets induced by VEGF (Fig. 3 a).
Synthetic inhibitors of signaling kinases have proven to be
extremely useful for investigating signal transduction path-
ways and are potentially of use for the treatment of various
human diseases in which growth factor signals play impor-
tant roles. Recently, synthetic compounds, e.g., SB-431542
 
(compound 14), that specifically inhibit the kinases of ALK-4,
-5, and -7 (a type I receptor for Nodal) have been identi-
fied (Callahan et al., 2002; Inman et al., 2002). They have
no effects on the other, more divergent ALK family type I
receptors that bind BMPs, or on other kinases including
ERK, JNK, and p38 MAPK. We tested the specificity of SB-
431542 for kinase activities of seven mammalian type I re-
ceptors for the TGF-
 
 
 
 superfamily (Fig. S1, available at
http://www.jcb.org/cgi/content/full/jcb.200305147/DC1),
and confirmed that SB-431542 is a specific inhibitor for
ALK-4, -5, and –7.
When SB-431542 was added to ESC-derived Flk1
 
 
 
 cells
in the presence of VEGF and TGF-
 
 
 
, it reversed the inhibi-
tion of formation of endothelial sheets by TGF-
 
 
 
 in a dose-
dependent manner (Fig. 3 b), suggesting that SB-431542 is
capable of inhibiting the ALK-5 kinase activity in these cells.
Next, we added SB-431542 to the ESC-derived in vitro vas-
cular differentiation culture containing VEGF in the absence
of exogenous TGF-
 
 
 
. Interestingly, the endothelial sheets
were significantly enlarged, and formed a fine cobblestone-
like structure (Fig. 3, c–e), which was observed in a dose-
dependent manner (Fig. 3 c). Similar results were obtained
with another ALK-4/-5/-7 kinase inhibitor, compound 13
(Callahan et al., 2002; unpublished data). These results sug-
gest that inhibition of ALK-4/-5/-7 kinase activities modifies
the growth and sheet formation of endothelial cells.
 
Quantitative analyses of the effects of TGF-
 
 
 
 signals on 
proliferation, differentiation, and integrity of ESC-derived 
endothelial cells
 
TGF-
 
 
 
 has been shown to have strong growth inhibitory ef-
fects on endothelial cells (Baird and Durkin, 1986). To ex-
amine the effects of TGF-
 
 
 
 on the proliferation of differen-
tiating vascular progenitor cells, we added TGF-
 
 
 
 or SB-
431542 to the Flk1
 
 
 
 cells in the presence of 10% FCS and
VEGF, and determined the change in cell number after 3 d
(Fig. 4 a). TGF-
 
 
 
 resulted in a reproducible decrease in cell
proliferation, whereas SB-431542 induced an increase in
proliferation, suggesting that TGF-
 
 
 
 signals inhibit the
growth of differentiating vascular progenitor cells. To exam-
ine whether this growth inhibitory effect of TGF-
 
 
 
 signals is
on endothelial cells or mural cells, we added TGF-
 
 
 
 or
SB-431542 to the Flk1
 
 
 
 cells in the presence of 10%
Figure 2. Expression of TGF-  superfamily sig-
naling components in ESC-derived vascular cells. 
RNA samples from CCE cell–derived Flk1  cells 
(FLK1 ), mural cells (MC), and mixed populations 
of endothelial and mural cells (EC   MC) were 
analyzed by RT-PCR for expression of TGF-  super-
family signaling components and the housekeeping 
gene  -actin to normalize the amount of total cDNA 
in each sample. As controls, RNAs from FLK1 , 
MC, and EC   MC were analyzed for  -actin 
expression without the prior generation of cDNA, 
and a PCR reaction for each set of primers was run 
against H2O. 
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FCS without VEGF, and determined the change in cell
number after 3 d (Fig. 4 b and Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200305147/DC1). Addi-
tion of TGF-
 
 
 
 resulted in a reproducible decrease in the
proliferation of mural cells, whereas SB-431542 induced an
increase in proliferation, suggesting that TGF-
 
 
 
 signals in-
hibit the growth of ESC-derived endothelial and mural cells.
To further dissect the roles of TGF-
 
 
 
 in the differentia-
tion of Flk1  cells into endothelial and mural cells, we per-
formed quantitative analyses using a limiting dilution assay.
When Flk1  cells were plated at a lower density, they
formed individual colonies, and the total number of colonies
varied depending on the culture conditions. TGF-  decreased
the number of colonies, whereas SB-431542 strongly in-
creased it (Fig. 4 c).
Next, we evaluated the phenotypes of the colonies by im-
munohistochemical analysis. Culturing Flk1  cells with
10% FCS resulted in colonies of a single type consisting of
pure mural cells positive for SMA. VEGF induced four types
of colonies emerging from single Flk1  cells: PECAM1 
pure endothelial cells with or without sheet structure (EC-
sheet and -scattered, respectively); pure mural cells (MC);
and mixtures of both (Mix; Fig. 4 c). The frequency of pure
endothelial cell colonies (EC-scattered and -sheet) was 25%.
Addition of TGF-  or SB-431542 reproducibly decreased
(22%) or increased (33%) this frequency, respectively, sug-
gesting that TGF-  signals modify the balance of differenti-
ation from vascular progenitor cells.
Although endothelial cells were observed in the presence
and absence of TGF-  signals, formation of endothelial
sheets was significantly affected (Fig. 4 c). The frequency of
sheet formation among pure endothelial colonies was 60%
when single Flk1  cells were cultured in the presence of
FCS and VEGF. When TGF-  was added, most endothelial
colonies exhibited scattered phenotypes, whereas 86% of en-
dothelial colonies formed sheet structures when SB-431542
was added (Fig. 4 c). In contrast, neither TGF-  or SB-
431542 altered the integrity of the mural cell colonies (Fig.
S2). Together with the finding that addition of SB-431542
increased the total number of vascular cells/colonies, these
results suggest that inhibition of endogenous TGF-  signals
results in enhancement of endothelial sheet formation.
Figure 3. Effects of various inhibitors 
of TGF-  superfamily members on 
ESC-derived vascular differentiation. 
(a) PECAM1 (purple) and SMA (brown) 
double immunostaining of differentiated 
Flk1  cells derived from CCE cells with 
10% FCS and VEGF in the absence or 
presence of follistatin, anti–TGF-  neutral-
izing antibodies, or both of them. (b) CCE 
cell–derived Flk1  cells were treated with 
TGF-  and different doses of SB-431542 
in the presence of 10% FCS and VEGF. 
(c) CCE cell–derived Flk1  cells were 
treated with different doses of SB-431542 
in the presence of 10% FCS and VEGF. 
(d) Low magnification images of PECAM1 
and SMA double immunostaining of 
differentiated Flk1  cells derived from 
CCE cells with 10% FCS in the absence 
or presence of VEGF in combination 
with TGF-  or SB-431542. (e) PECAM1 
(red) and SMA (green) double immuno-
fluorescence staining of differentiated 
Flk1  cells derived from CCE cells with 
10% FCS in the absence or presence of 
VEGF in combination with TGF-  or 
SB-431542. Bars: (a–c and e) 100  m; 
(d) 5 mm.TGF-  signals in vascular development | Watabe et al. 1307
Activation of R-Smads by TGF-  superfamily signals in 
ESC-derived vascular cells
To examine the activity of endogenous TGF-  signals in
ESC-derived endothelial cells, we examined phosphoryla-
tion of R-Smads by a phospho-Smad1/5 antibody and a
phospho-Smad2 antibody. Stimulation of mixed popula-
tions of endothelial and mural cells with TGF-  for 1 h re-
sulted in phosphorylation of both Smad2 and Smad1/5 (Fig.
5 a, lane 3), as reported previously in other types of primary
endothelial cells (Goumans et al., 2002).
Next, we examined dose-dependent effects of TGF-  on
the phosphorylation of Smads in ESC-derived vascular cells.
In mouse embryonic endothelial cells, ALK-5–mediated
Smad2 phosphorylation was induced substantially at 0.025
ng/ml of TGF-  and reached a maximum at 0.25 ng/ml,
which remained at this level at higher doses, whereas ALK-
1–mediated Smad1/5 phosphorylation was induced at low
doses (0.25–0.5 ng/ml) of TGF-  but was decreased at 1
ng/ml (Goumans et al., 2002). We have shown that TGF- 
does not elicit biphasic effect on the formation of ESC-
derived vascular cells (Fig. 1 b). In agreement with this finding,
when different doses of TGF-  were added to the culture of
Flk1  cells in the presence of VEGF, Smad2 phosphoryla-
tion was significantly induced and reached a maximum at
0.03 ng/ml of TGF- , which remained at this level at higher
doses; whereas Smad1/5 phosphorylation was significantly
induced at 0.03 ng/ml, and reached a maximum at 1 ng/ml,
which remained at this level at higher doses (Fig. 5 b). These
results suggest that TGF-  does not elicit biphasic effects in
the phosphorylation of Smads in ESC-derived vascular cells.
As expected, BMP7 led to phosphorylation of only Smad1/5
(Fig. 5 a, lane 5) whereas activin led to phosphorylation of
only Smad2 (Fig. 5 a, lane 7). To evaluate whether TGF- -
induced Smad5 phosphorylation is specific to endothelial
cells, we analyzed phosphorylation of Smads by TGF-  in
ESC-derived mural cells. Although TGF-  induced Smad2
phosphorylation in mural cells (Fig. 5 a, lane 10), it failed to
phosphorylate Smad1/5. BMP led to phosphorylation of
Smad1/5 in mural cells (Fig. 5 a, lane 11). These results sug-
gest that TGF-  induced phosphorylation of both Smad2
and Smad1/5 only in ESC-derived endothelial cells.
To confirm that Smad1/5 as well as Smad2 is activated by
TGF-  in ESC-derived endothelial cells, nuclear transloca-
tion of Smad proteins was studied using an antiphospho-
Smad1/5 antibody and an anti-Smad2 antibody. TGF-  in-
duced nuclear translocation of Smad2, whereas BMP failed
to do it (Fig. 5 c). In agreement with the results of Western
blot analysis, both TGF-  and BMP induced nuclear trans-
location of phosphorylated Smad1/5 in ESC-derived endo-
thelial cells (Fig. 5 c).
When SB-431542 was added in the presence of TGF-  or
activin, Smad2 phosphorylation was decreased in a dose-
dependent manner because of its inhibitory effect on ALK-5
and -4, respectively (Fig. 5 a, lane 4 and 8, respectively; Fig.
5 d). We found that Smad1/5 phosphorylation induced by
TGF-  was also decreased by SB-431542 (Fig. 5 a, lane 4).
Because SB-431542 is not capable of inhibiting Smad phos-
phorylation by ALK-1 (Fig. S1), these results suggest that
ALK-5 kinase activity is required for ALK-1–mediated phos-
phorylation of Smad1/5 in ESC-derived endothelial cells.
Inhibition of Smad1/5 phosphorylation by SB-431542 is
specific for ALK-1 because Smad1/5 phosphorylation by
BMP was not decreased by SB-431542 (Fig. 5 a, lane 6).
Importantly, phosphorylation of Smad2 was weakly de-
tected in the absence of exogenous ligands (Fig. 5 a, lane
1), suggesting that endogenous TGF-  or activin (Fig. 2)
Figure 4.  Quantitative analyses of the effects of 
TGF-  signals on ESC-derived vascular differentia-
tion. (a and b) Effect of TGF-  signals on proliferation 
of Flk1  cells during vascular differentiation. 10
5 
Flk1  cells derived from CCE cells were cultured 
in the presence (a) or absence (b) of VEGF in 
combination with TGF-  or SB-431542, followed 
by determination of cell number after 3 d. Error bars 
represent SD. (c) Quantitation of colony formation, 
endothelial and mural cell production and endo-
thelial sheet formation. Flk1  cells were cultured 
sparsely with 10% FCS in the absence or presence 
of VEGF in combination with TGF-  or SB-431542 
for 4 d, and stained for PECAM1 and SMA. Number 
of colonies per well was counted to determine the 
effect of TGF-  signals on colony formation of Flk1  
cells. Experiments were repeated at least three times 
with essentially same results. Four colony types 
were observed; pure endothelial cells forming sheet 
structures (EC-sheet): pure scattered endothelial cells 
(EC-scattered); pure mural cells (MC); and mixed 
colonies consisting of endothelial and mural cells 
(Mix). Bars, 50  m.1308 The Journal of Cell Biology | Volume 163, Number 6, 2003
acts on these cells. Moreover, addition of SB-431542 re-
sulted in the decrease of phospho-Smad2 in these cells in a
dose-dependent manner (Fig. 5 a, lane 2; Fig. 5 e). SB-
431542 substantially decreased Smad2 phosphorylation at
0.1   M and reached a maximum at 1  M, which re-
mained at this level at higher doses (Fig. 5 e). In accor-
dance with this result, the enhancement of endothelial
sheet formation by SB-431542 was elevated gradually and
reached a maximum at 1  M (Fig. 3 c). These results
strongly implicate the causal link between the states of
Smad2 phosphorylation induced by TGF-  signals and en-
dothelial sheet formation.
TGF-  regulates integrity of ESC-derived endothelial 
cells through claudin-5 expression
Next, we attempted to elucidate the molecular mechanisms
by which endogenous TGF-  signals regulate the integrity
of endothelial sheets. Integrity of cell–cell contacts is vital
for functioning of endothelial cells as barriers and fences be-
tween the blood and extravascular components. Endothelial
cell–cell junctions such as TJs are thought to control not
only normal physiological conditions such as vascular per-
meability, leukocyte extravasation, and the formation and
outgrowth of blood vessels, but also pathological conditions
such as vasogenic edema (Morita et al., 1999).
Because TGF-  signals regulate ESC-derived endothelial
sheet formation (Fig. 3 b), we searched for the molecular tar-
gets of ALK-5 signals. Recently, we conducted oligonucle-
otide microarray analysis to identify target genes of ALK-1
and -5 in human umbilical vein endothelial cells (Ota et al.,
2002). One of the genes down-regulated by constitutively
active ALK-5 was claudin-5, a component of TJ expressed
exclusively in endothelial cells (Morita et al., 1999).
To study the effects of TGF-  signals on claudin-5 expres-
sion in ESC-derived endothelial cells, we performed quanti-
tative RT-PCR analysis against mural cells obtained in the
absence of VEGF, and mixed populations of endothelial and
mural cells differentiated in the presence of VEGF (Fig. 6 a).
Claudin-5 expression was detected in the populations con-
taining endothelial cells. TGF-  suppressed the expression of
claudin-5, whereas SB-431542 strongly enhanced its expres-
sion (Fig. 6 a). Interestingly, TGF-  signals did not alter the
expression of other components of TJs such as claudin-12
(Fig. 6 a; Tsukita et al., 2001), or VE-cadherin (a component
of adherens junctions; unpublished data), suggesting that ef-
fects of TGF-  signals on endothelial integrity may be pri-
marily mediated by transcriptional regulation of claudin-5.
The above results were confirmed by immunofluorescence
staining of claudin-5 (Fig. 6 b). Claudin-5 was concentrated
at cell–cell borders of PECAM1  endothelial cells (Fig. 6 b,
top). When these endothelial cells were treated with TGF- ,
expression of claudin-5 was decreased in accordance with the
disruption of endothelial sheet structure, and claudin-5 was
not detected at cell–cell borders (Fig. 6 b, middle). When
these endothelial cells were treated with SB-431542, clau-
din-5 expression was strongly increased with the enhance-
ment of endothelial sheet formation (Fig. 6 b, bottom).
TGF-  regulates formation of endothelial sheets 
derived from 8.5-dpc mouse embryos
To examine the roles of TGF-  signals during vascular devel-
opment in mice, we tested the effects of TGF-  and SB-
431542 on the differentiation of Flk1  cells obtained from
8.5-dpc mouse embryos. When embryo-derived Flk1  cells
were cultured with 10% FCS,  95% cells became positive
for SMA (Fig. 7 a). When 100 ng/ml VEGF was added, we
Figure 5. TGF-  induced phosphoryla-
tion and nuclear translocation of Smad2 
and Smad1/5 in ESC-derived endothelial 
cells. (a) Phosphorylation of R-Smads by 
TGF-  superfamily members in ESC-
derived endothelial and mural cells. Flk1  
cells were cultured with 10% FCS and 
VEGF for 3 d to induce differentiation into 
endothelial and mural cells, and treated 
with TGF-  or BMP7 in the absence or 
presence of SB-431542 for 1 h. Mural 
cells differentiated from Flk1  cells with 
10% FCS were treated with TGF-  for 1 h. 
Cell lysates were directly subjected to 
immunoblotting using phospho-Smad2 
(top), and phospho-Smad1/5 (bottom) 
antibodies. (b) Dose response of TGF-  
induced Smad2 versus Smad1/5 phos-
phorylation. Flk1  cells were cultured 
with 10% FCS and VEGF for 3 d to induce 
differentiation into endothelial and mural 
cells, and treated with different concen-
trations of TGF-  for 1 h. (c) Nuclear 
translocation of R-Smads by TGF-  and 
BMP in ESC-derived endothelial cells. Endothelial cells differentiated from Flk1  cells by VEGF in serum-free culture (Yamashita et al., 2000) 
were untreated (left) or treated with TGF-  (middle) or BMP7 (right) for 1 h, and subjected to immunofluorescence staining using phospho-Smad2 
(top) and phospho-Smad1/5 (bottom) antibodies (green) and observation by confocal microscopy. (Insets) immunofluorescence staining of the 
same fields for PECAM1 (red). Bars, 200  m. (d and e) Dose response effects of SB-431542 on Smad2 phosphorylation induced by exogenous 
or endogenous TGF- . Flk1  cells were cultured with 10% FCS and VEGF for 3 d to induce differentiation into endothelial and mural cells, 
and treated with different concentrations of SB-431542 for 1 h in the (d) presence or (e) absence of exogenous TGF- .TGF-  signals in vascular development | Watabe et al. 1309
were able to obtain PECAM1-positive sheets of endothelial
cells. When TGF-  was added to the culture in the presence
of VEGF, it inhibited the growth and integrity of endothelial
cells. In contrast, SB-431542 strongly facilitated them. Subse-
quently, the effects of TGF-  signals on claudin-5 expres-
sion were examined by immunofluorescence staining (Fig.
7 b). Claudin-5 was concentrated at cell–cell borders of
PECAM1  endothelial cells. When these embryo-derived
endothelial cells were treated with TGF- , claudin-5 expres-
sion was decreased, whereas SB-431542 increased the expres-
sion of claudin-5, in accordance with alteration of endothelial
sheet formation. These results strongly suggest that TGF- 
signals play roles in vascular development in mouse embryos
similar to those in ESC-derived vascular progenitor cells.
Discussion
Here, we showed that TGF-  superfamily signals play im-
portant roles during differentiation of vascular progenitor
cells derived from ESC and embryos. TGF-  signals have
two distinct effects on vascular formation. First, they de-
crease the number of vascular (endothelial and mural) cells
differentiating from vascular progenitor cells. This inhibi-
tory effect on cell proliferation was not specific to endothe-
lial cells. In fact, addition of TGF-  decreased the number
of mural cells in the presence or absence of VEGF (Fig. 4 b
and unpublished data). The inhibitory effects of TGF-  sig-
nals on the growth (Fig. 4, a and b) and colony formation
(Fig. 4 c) of Flk1  cells could be the result of a decrease in
proliferation rate, an increase in cell death, or a combination
of these two as previously reported (Baird and Durkin,
1986; Pollman et al., 1999). Second, TGF-  decreased the
integrity of endothelial sheets via down-regulation of clau-
din-5 expression. Interestingly, TGF-  selectively repressed
the expression of claudin-5 but not that of other molecules
involved in TJs (Fig. 6). These findings may help answer the
question how TGF-  can function as both an inhibitor and
a promoter of vasculogenesis and angiogenesis.
Endothelial cells express two types of TGF-  type I recep-
tors, i.e., ALK-1 and -5, transducing distinct Smad path-
Figure 6.  Effect of TGF-  signals on 
expression of claudin-5 in ESC-derived 
endothelial cells. (a) Levels of expression 
of claudin-5 and -12 in vascular cells 
derived from MGZ5 cells cultured in the 
absence or presence of VEGF in combina-
tion with TGF-  or SB-431542 analyzed 
by quantitative real-time RT-PCR. Error 
bars represent SD. (b) Claudin-5 (left, 
green) and PECAM1 (right, red) double 
immunofluorescence staining of differ-
entiated Flk1  cells with 10% FCS and 
VEGF alone (top), or in combination with 
TGF-  (middle) or SB-431542 (bottom). 
To obtain similar numbers of endothelial 
cells, different numbers of Flk1  cells 
were plated depending on the culture 
conditions. Bars, 200  m.
Figure 7. Effects of TGF-  signals on 
vascular differentiation of Flk1  cells 
from 8.5-dpc embryos. (a) PECAM1 
(purple) and SMA (brown) double immu-
nostaining of differentiated Flk1  cells 
derived from mouse embryos with 10% 
FCS in the absence or presence of VEGF 
in combination with TGF-  or SB-431542. 
(b) Claudin-5 (green) and PECAM1 (red) 
double immunofluorescence staining of 
differentiated embryo-derived Flk1  cells 
with 10% FCS and VEGF alone, or in 
combination with TGF-  or SB-431542. 
To obtain similar numbers of endothelial 
cells, different numbers of Flk1  cells 
were plated depending on the culture 
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ways. Goumans et al. (2002) showed that these distinct sig-
naling pathways have opposite effects on endothelial cells,
and that their balance contributes to both pro- and anti-
angiogenic properties of TGF- . The ALK-5–Smad2/3 path-
way inhibits cell proliferation and migration, whereas the
ALK-1–Smad1/5 pathway induces them (Goumans et al.,
2002). Here, TGF-  and activin inhibited the proliferation
and sheet formation of ESC-derived endothelial cells. Al-
though TGF-  also activated ALK-1–Smad1/5 pathways in
ESC-derived endothelial cells (Fig. 5), the biological effects
observed in the present paper appear to be more dependent
on the Smad2/3 pathways because similar results were ob-
tained with activin, which activates only Smad2/3 pathways.
Phosphorylation of Smad2 was weakly detected in the ab-
sence of exogenous ligands (Fig. 5 a, lane 1), suggesting that
endogenous TGF-  or activin acts on these cells. TGF- s
are released from cells in latent forms consisting of the ma-
ture growth factors associated with amino-terminal propep-
tides and latent TGF- –binding proteins (Annes et al.,
2003). Endogenous activation of latent TGF-  has been
shown to occur efficiently in cocultures of endothelial and
smooth muscle cells through activation of plasmin on the
cell surface, suggesting that endogenous TGF-  may regu-
late the functions of ESC-derived vascular cells.
Phosphorylation of Smad1/5 was also weakly detected in
the absence of exogenous ligands (Fig. 5 a, lane 1). Although
either endogenous TGF-  or BMPs can activate Smad1/5
through ALK-1 or BMP type I receptors, this activation ap-
pears to be mediated by BMP signals because SB-431542
could not inhibit it. BMP signals have been implicated in
maintenance of vascular homeostasis by the findings that
heterozygous mutations in BMP type II receptor gene cause
human primary pulmonary hypertension (The International
PPH Consortium, 2000; Nishihara et al., 2002). The roles
of BMP signals in endothelial differentiation from ESC-
derived vascular progenitor cells remain to be elucidated.
SB-431542, which inhibits ALK-4/-5/-7 kinase activities,
stimulated proliferation, differentiation, and sheet forma-
tion of ESC-derived endothelial cells. All of these effects ap-
pear to improve the quantity and quality of endothelial
sheets differentiated from vascular progenitor (Flk1 ) cells.
Vascular progenitor cells prepared from either ESC or pe-
ripheral blood cells are expected to be useful for therapeutic
angiogenesis in various vascular diseases. However, they may
differentiate into smooth muscle cells as well as endothelial
cells, and may potentially aggravate vascular diseases such as
atherosclerosis (Sata et al., 2002). TGF-  receptor kinase in-
hibitors might thus become invaluable for obtaining highly
enriched, mature endothelial cells ex vivo. In addition, be-
cause VEGF increases vascular permeability (Senger et al.,
1983), it may contribute to the progression of tissue edema
if used in vascular regenerative medicine. Therefore, ALK-4/
-5/-7 kinase inhibitors might also be useful for regulation of
vascular permeability, and maintenance of vascular integrity,
in order to prevent tissue edema.
In brain endothelial cells, claudin-5 and -12 are major cell
adhesion molecules of TJs (Nitta et al., 2003). Recently,
claudin-5–deficient mice were generated, and their blood-
brain barrier (BBB) was found to be selectively permissive
for small molecules ( 800 D), but not for larger ones (Nitta
et al., 2003). This finding promised a new approach to de-
liver potential drugs across the BBB into the central nervous
system. Our findings revealed that TGF-  signals specifi-
cally down-regulate the expression of claudin-5, and not that
of claudin-12, resulting in inhibition of endothelial integ-
rity. Thus, specific acceleration of TGF-  signaling in brain
endothelial cells may size-selectively loosen the BBB to de-
liver the drugs of small molecular size into the central ner-
vous system.
Materials and methods
Preparation of SB-431542
SB-431542 (compound 14) and compound 13 were synthesized as de-
scribed previously (Callahan et al., 2002). A solution of SB-431542 in
DMSO was prepared. This solution was used after diluting with medium
for each assay.
Cells and cell culture
Maintenance, differentiation, culture, and cell sorting of CCE and MGZ5
ES cells (gifts from M.J. Evans [University of Cambridge, Cambridge, UK]
and H. Niwa [RIKEN, CDB, Kobe, Japan], respectively) were performed as
described previously (Yamashita et al., 2000). All experiments were per-
formed using both ES cell lines and yielded essentially similar results.
Flk1  cells were also obtained from 8.5-dpc mouse embryos that were di-
gested by disperse II (Roche). 30 ng/ml VEGF, 500 ng/ml BMP7, 3 ng/ml
TGF- , 100 ng/ml activin, and 1  M SB-431542 were used in each exper-
iment unless specifically described.
Immunohistochemistry and Western blot analysis
mAbs for PECAM1 (Mec13.3), SMA (1A4), and claudin-5 for immunohis-
tochemistry were purchased from BD Biosciences, Sigma-Aldrich, and
Zymed Laboratories, respectively. Staining of culture cells was performed
as described previously (Yamashita et al., 2000). Stained cells were photo-
graphed using a phase-contrast microscope (model IX70; Olympus) or a
confocal microscope (model LSM510 META; Carl Zeiss MicroImaging,
Inc.). All images were imported into Adobe Photoshop as JPEGs for con-
trast manipulation and figure assembly. Antibodies for phospho-Smad2
and phospho-Smad1/5 for Western blot analysis and immunohistochemis-
try were obtained from Cell Signaling and Santa Cruz Biotechnologies,
Inc., respectively. Western blot analysis was performed as described previ-
ously (Kawabata et al., 1998).
RNA isolation and RT-PCR
After 3 d of culture of Flk1  cells with 10% FCS in the absence or pres-
ence of VEGF, TGF- , or SB-431542, cells were used as a source of RNA.
Total RNA was prepared with ISOGEN reagent (Nippongene) according
to the manufacturer’s instructions, and reverse transcribed by oligo (dT)
priming and PowerScript-Reverse Transcriptase (CLONTECH Laboratories,
Inc.). Expression of various signaling components was compared by semi-
quantitative RT-PCR analysis. PCR products were separated by electro-
phoresis in 1% agarose gel and visualized with ethidium bromide. Quanti-
tative RT-PCR analysis was performed using the GeneAmp 5700 Sequence
Detection System (Applied Biosystems). The primer sequences and ex-
pected sizes of PCR products are available online as indicated in Table S1,
available at http://www.jcb.org/cgi/content/full/jcb.200305147/DC1.
Online supplemental material
Fig. S1 shows the specificity of SB-431542 in the inhibition of TGF-  su-
perfamily type I receptors. Fig. S2 shows the effects of TGF-  and SB-
431542 on ESC-derived mural cell differentiation. Table S1 indicates the
primer sequences and expected sizes of PCR products. The online sup-
plemental material is available at http://www.jcb.org/cgi/content/full/
jcb.200305147/DC1.
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